Daiichi/AZ

Daiichi/AZ is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Daiichi/AZ products.

Drugs from Daiichi/AZ supported via NPP

BrandGenericCategoryIndication
Enhertutrastuzumab deruxtecanOncology (Breast/Gastric)HER2 solid tumors

How NPP access to Daiichi/AZ products works

Reserve Meds sources Daiichi/AZ products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.

Not affiliated with Daiichi/AZ

Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Daiichi/AZ.

Start a request

Start a request for a Daiichi/AZ product

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp